The public and private lives of psychopharmaceuticals in the global South: The Sedated Society: The Causes and Harms of our Psychiatric Drug Epidemic

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The chapter focuses on the global spread of psychopharmaceuticals, discussing how in 1990s psychopharmaceuticals were cast as heralding a new era of treating mental ills. Yet this hope, or hype, started to wane in the 2000s, and even large pharmaceutical companies are now withdrawing from this segment. Doubt about psychopharmaceuticals has even gained ground in the more recent policies of the World Health Organisation, which has moved from advocating drugs as the best first-line treatment to a greater emphasis on non-pharmacological therapies.The “public lives” of drugs that are captured by WHO treatment gap calculations are shown to be cut off from the “private lives” of psychopharmaceuticals in the prescriptions of nonspecialists in the private market. Drugs are circulating far more widely than is known, and the influence of manufacturers onto prescription patterns is far stronger than is assumed
Original languageEnglish
Title of host publicationThe Sedated Society
Subtitle of host publicationThe Causes and Harms of our Psychiatric Drug Epidemic
EditorsJames Davies
PublisherSpringer International Publishing
Pages249-269
Number of pages21
Edition1
ISBN (Electronic)978-3-319-44911-1
ISBN (Print)978-3-319-44910-4
DOIs
Publication statusPublished - 2 Feb 2017

Fingerprint Dive into the research topics of 'The public and private lives of psychopharmaceuticals in the global South: The Sedated Society: The Causes and Harms of our Psychiatric Drug Epidemic'. Together they form a unique fingerprint.

Cite this